Michael Youngman

Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

Pek Y. Chong, Paul R. Sebahar, Michael Youngman et al. · Journal of Medicinal Chemistry · 2012 · 54 citations

Molecular Biology, New Series, Imidazole-amide Biarylether Scaffold +17

Hepatitis C Replication Inhibitors That Target the Viral NS4B Protein

John F. Miller, Pek Y. Chong, J. Brad Shotwell et al. · Journal of Medicinal Chemistry · 2013 · 45 citations · Full text

Viral Replication, Immunology, Molecular Biology +19

Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1

Wieslaw M. Kazmierski, Christopher Aquino, Brian A. Chauder et al. · Journal of Medicinal Chemistry · 2008 · 32 citations · Full text

Novel 4,4-Disubstituted Piperidine-Based C–C Chemokine Receptor-5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved human Ether-a-go-go Related Gene (hERG) Profile

Wieslaw M. Kazmierski, Don L. Anderson, Christopher Aquino et al. · Journal of Medicinal Chemistry · 2011 · 29 citations · Full text

Strong Anti-hiv Potency, Immunology, Clinical Compound 122 +17

Synthesis and evaluation of hexahydrochrysene and tetrahydrobenzofluorene ligands for the estrogen receptor

Rosanna Tedesco, Michael Youngman, Scott R. Wilson et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 26 citations

Tetrahydrobenzofluorene Ligands, Hormonal Receptor, Estrogen Receptor +4